Company facts
- Headquarters
- Charlotte, North Carolina
- Most recent report
- 10-Q, filed Aug 13, 2026
- Incorporated
- Delaware
- Filings on record
- 69 filings
- On EDGAR
- CIK 1938571
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 13
News 6
Prospectuses and Registrations 8 of 11
- POS AM Post-effective amendment to a registration Jul 21, 2026
- 424B3 Prospectus supplement for an offering Jun 12, 2026
- 424B3 Prospectus supplement for an offering May 18, 2026
- 424B3 Prospectus supplement for an offering Nov 17, 2025
- 424B3 Prospectus supplement for an offering Oct 7, 2025
- S-8 Registration statement for an employee plan Aug 15, 2025
- 424B3 Prospectus supplement for an offering Aug 15, 2025
- 424B3 Prospectus supplement for an offering Aug 5, 2025
Ownership 8 of 19
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- 4 Insider reported a trade Sep 10, 2025
- SCHEDULE 13D Large holder reported an active stake Feb 18, 2025
Other 8 of 20
- EFFECT Notice that a registration became effective Jul 22, 2026
- D/A Amended filing Jun 22, 2026
- NT 10-K Notice that an annual report will be late Apr 1, 2026
- D/A Amended filing Mar 23, 2026
- D/A Amended filing Feb 20, 2026
- D Jan 5, 2026
- EFFECT Notice that a registration became effective Aug 4, 2025
- CORRESP Reply to SEC staff Jul 31, 2025
Everything here comes from Adaptin Bio, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.